Literature DB >> 18693098

Effects of the active constituents of Crocus sativus L., crocins, in an animal model of anxiety.

N Pitsikas1, A Boultadakis, G Georgiadou, P A Tarantilis, N Sakellaridis.   

Abstract

Crocus sativus L. is a plant cultivated in various parts of the world. Crocins are among the active components of Crocus sativus L. The present study was designed to investigate in the rat whether or not crocins possess anxiolytic properties. For this aim, the light/dark test was selected. Either crocins, at a dose which did not influence animals' motor activity (50mg/kg), or diazepam (1.5 mg/kg), significantly increased the latency to enter the dark compartment and prolonged the time spent in the lit chamber in the rats. Conversely, lower doses of crocins (15-30 mg/kg) did not substantially modify animals' behaviour. The present results indicate that treatment with these active constituents of Crocus sativus L. induce anxiolytic-like effects in the rat.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18693098     DOI: 10.1016/j.phymed.2008.06.005

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  31 in total

Review 1.  Plant-based medicines for anxiety disorders, Part 1: a review of preclinical studies.

Authors:  Jerome Sarris; Erica McIntyre; David A Camfield
Journal:  CNS Drugs       Date:  2013-03       Impact factor: 5.749

Review 2.  Was Hawan Designed to Fight Anxiety-Scientific Evidences?

Authors:  R K Romana; A Sharma; V Gupta; R Kaur; S Kumar; P Bansal
Journal:  J Relig Health       Date:  2020-02

3.  Crocus sativus L.: A comprehensive review.

Authors:  R Srivastava; H Ahmed; R K Dixit; S A Saraf
Journal:  Pharmacogn Rev       Date:  2010-07

4.  Crocins, the active constituents of Crocus Sativus L., counteracted ketamine-induced behavioural deficits in rats.

Authors:  Georgia Georgiadou; Vasilios Grivas; Petros A Tarantilis; Nikolaos Pitsikas
Journal:  Psychopharmacology (Berl)       Date:  2013-10-06       Impact factor: 4.530

5.  Saffron reduces ATP-induced retinal cytotoxicity by targeting P2X7 receptors.

Authors:  Lucia Corso; Anna Cavallero; Debora Baroni; Patrizia Garbati; Gianfranco Prestipino; Silvia Bisti; Mario Nobile; Cristiana Picco
Journal:  Purinergic Signal       Date:  2016-01-07       Impact factor: 3.765

6.  The metabotropic glutamate 2/3 receptor agonist LY379268 induces anxiety-like behavior at the highest dose tested in two rat models of anxiety.

Authors:  Vasilios Grivas; Athina Markou; Nikolaos Pitsikas
Journal:  Eur J Pharmacol       Date:  2013-06-11       Impact factor: 4.432

7.  New minor glycoside components from saffron.

Authors:  Nguyen Huu Tung; Yukihiro Shoyama
Journal:  J Nat Med       Date:  2012-11-21       Impact factor: 2.343

Review 8.  Crocus Sativus L. (Saffron) in Alzheimer's Disease Treatment: Bioactive Effects on Cognitive Impairment.

Authors:  Grazia D'Onofrio; Seyed Mohammad Nabavi; Daniele Sancarlo; Antonio Greco; Stefano Pieretti
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

9.  Effect of Aqueous Extract of Crocus sativus L. on Morphine-Induced Memory Impairment.

Authors:  Sayede Maryam Naghibi; Mahmoud Hosseini; Fatemeh Khani; Motahare Rahimi; Farzaneh Vafaee; Hassan Rakhshandeh; Azita Aghaie
Journal:  Adv Pharmacol Sci       Date:  2012-10-10

10.  Safranal, a saffron constituent, attenuates retinal degeneration in P23H rats.

Authors:  Laura Fernández-Sánchez; Pedro Lax; Gema Esquiva; José Martín-Nieto; Isabel Pinilla; Nicolás Cuenca
Journal:  PLoS One       Date:  2012-08-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.